These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 17531530)
1. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530 [TBL] [Abstract][Full Text] [Related]
2. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242 [TBL] [Abstract][Full Text] [Related]
3. LPA Hao F; Liu Q; Zhang F; Du J; Dumire A; Xu X; Cui MZ J Biol Chem; 2021 Oct; 297(4):101152. PubMed ID: 34478715 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway. Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333 [TBL] [Abstract][Full Text] [Related]
5. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Goppelt-Struebe M; Fickel S; Reiser CO Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524 [TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Kim J; Keys JR; Eckhart AD Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway. Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702 [TBL] [Abstract][Full Text] [Related]
11. LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis. Windischhofer W; Huber E; Rossmann C; Semlitsch M; Kitz K; Rauh A; Devaney T; Leis HJ; Malle E Biochimie; 2012 Sep; 94(9):1997-2005. PubMed ID: 22659570 [TBL] [Abstract][Full Text] [Related]